MGNX

Biotechnology INCY MGNX NONOF NVO Uncategorized

Incyte fails to win FDA label expansion for cancer therapy due to issues at Novo plant

Mar 7, 2026

Biotechnology INCY MGNX Uncategorized

Incyte wins EU backing for MacroGenics-partnered cancer drug in GIT indication

Jan 30, 2026